Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.

[1]  Yongbing Chen,et al.  Relationship between MTA1 and spread through air space and their joint influence on prognosis of patients with stage I-III lung adenocarcinoma. , 2018, Lung cancer.

[2]  Qiong Yang,et al.  Metastasis-associated protein 1 (MTA1) in gastric cancer tissues is positively associated with poorer prognosis. , 2018, Pathology, research and practice.

[3]  Christian R Gomez,et al.  Targeting MTA1/HIF‐1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression , 2017, Cancer medicine.

[4]  J. Lewin,et al.  Targeting MTA1/HIF-1alpha Signaling by Pterostilbene in Combination with Histone Deacetylase Inhibitor Attenuates Prostate Cancer Progression (Open Access) , 2017 .

[5]  Chad J. Creighton,et al.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.

[6]  Beicheng Sun,et al.  MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway , 2017, Oncogene.

[7]  Cunchuan Wang,et al.  MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  F. Edfors,et al.  Gene‐specific correlation of RNA and protein levels in human cells and tissues , 2016, Molecular systems biology.

[9]  Handong Ma,et al.  MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2 , 2016, Oncotarget.

[10]  L. I. Li,et al.  Endocrine MPA enhances the effects of TAC chemotherapy on improvement of prognosis and increase in long-term survival rates for patients with endometrial cancer. , 2015, Oncology letters.

[11]  Hong Zhang,et al.  miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion. , 2015, Acta biochimica et biophysica Sinica.

[12]  G. Tzivion,et al.  Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. , 2015, Biochimica et biophysica acta.

[13]  Qiong Zhang,et al.  Expression of MTA1 in nasopharyngeal carcinoma and its correlation with prognosis , 2014, Medical Oncology.

[14]  Hao Zhang,et al.  Molecular functions and significance of the MTA family in hormone-independent cancer , 2014, Cancer and Metastasis Reviews.

[15]  Rui‐an Wang.  MTA1—a stress response protein: a master regulator of gene expression and cancer cell behavior , 2014, Cancer and Metastasis Reviews.

[16]  B. Xia,et al.  MTA1 Overexpression Induces Cisplatin Resistance Innasopharyngeal Carcinoma by Promoting Cancer Stem Cells Properties , 2014, Molecules and cells.

[17]  Jian Li,et al.  Estrogen Regulates the Tumour Suppressor MiRNA-30c and Its Target Gene, MTA-1, in Endometrial Cancer , 2014, PloS one.

[18]  C. Deng,et al.  Metastasis-associated protein 1 is an integral component of the circadian molecular machinery , 2013, Nature Communications.

[19]  H. Zhang,et al.  The Metastasis-Associated Gene MTA3, a Component of the Mi-2/NuRD Transcriptional Repression Complex, Predicts Prognosis of Gastroesophageal Junction Adenocarcinoma , 2013, PloS one.

[20]  Yi Zheng,et al.  MTA1 promotes STAT3 transcription and pulmonary metastasis in breast cancer. , 2013, Cancer research.

[21]  Da-Qiang Li,et al.  A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes. , 2013, Molecular cell.

[22]  N. Yang,et al.  β-elemene acts as an antitumor factor and downregulates the expression of survivin, Bcl-xL and Mta-1. , 2012, Molecular medicine reports.

[23]  R. Coleman,et al.  The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer , 2012, Clinical Cancer Research.

[24]  Rakesh Kumar,et al.  Metastasis-associated Protein 1/Histone Deacetylase 4-Nucleosome Remodeling and Deacetylase Complex Regulates Phosphatase and Tensin Homolog Gene Expression and Function* , 2012, The Journal of Biological Chemistry.

[25]  A. Brüning,et al.  The metastasis‐associated gene MTA3 is an independent prognostic parameter in uterine non‐endometrioid carcinomas , 2012, Histopathology.

[26]  G. Scambia,et al.  Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study. , 2012, Human pathology.

[27]  Xiaofeng Xu,et al.  microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1. , 2011, Oncology reports.

[28]  L. Mishra,et al.  TGF-β1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells , 2011, Oncogene.

[29]  P. Dash,et al.  Multiple coregulatory control of tyrosine hydroxylase gene transcription , 2011, Proceedings of the National Academy of Sciences.

[30]  A. Brüning,et al.  The metastasis-associated gene MTA3 is downregulated in advanced endometrioid adenocarcinomas. , 2010, Histology and histopathology.

[31]  S. Rayala,et al.  Metastasis-associated protein 1 and its short form variant stimulates Wnt1 transcription through promoting its derepression from Six3 corepressor. , 2010, Cancer research.

[32]  K. Shokat,et al.  Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. , 2010, Cancer cell.

[33]  K. Ohshiro,et al.  MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions. , 2009, Cancer research.

[34]  W. Weichert,et al.  Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro , 2009, Journal of Cancer Research and Clinical Oncology.

[35]  U. Jeschke,et al.  The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERβ, and enhances expression of oncogenic cytokine GRO , 2008, Cancer biology & therapy.

[36]  E. Yu,et al.  Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma , 2008, Hepatology.

[37]  Rakesh Kumar,et al.  Metastasis Tumor Antigens, an Emerging Family of Multifaceted Master Coregulators* , 2007, Journal of Biological Chemistry.

[38]  R. Broaddus,et al.  Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas. , 2006, Human pathology.

[39]  Rakesh Kumar,et al.  Emerging roles of MTA family members in human cancers. , 2003, Seminars in oncology.

[40]  Carlos S. Moreno,et al.  MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer , 2003, Cell.

[41]  Weidong Wang,et al.  NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. , 1998, Molecular cell.

[42]  G. Nicolson,et al.  A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. , 1994, The Journal of biological chemistry.

[43]  Da-Qiang Li,et al.  Unravelling the Complexity and Functions of MTA Coregulators in Human Cancer. , 2015, Advances in cancer research.

[44]  Sandip K. Mishra,et al.  Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor , 2000, Nature Cell Biology.